Chief Executive Officer
Tue, Feb 17, 2026
Feb 17
8,159 shares @ $39.22
Decreased holdings by -2.70%
Net across this filing: 0.00% (+0 shares)
7th largest trade (out of 42)
Tax Sell-to-Cover
Trade made by an officer
Automatic sale to cover taxes on a vest — not a discretionary trade
Net holdings across this filing: +0.0% (+0 shares)
Price 150% above 200-day moving average
TERNTerns Pharmaceuticals, Inc.
HealthcareBiotechnology